Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Torrent Pharma
Join Channel
Consolidated Standalone

Torrent Pharma

₹3409.8 8.6 | 0.3%

Market Cap ₹115401 Cr.

Stock P/E 69.7

P/B 15.3

Current Price ₹3409.8

Book Value ₹ 222.4

Face Value 5

52W High ₹3590

Dividend Yield 0.82%

52W Low ₹ 2248.7

Edit Ratio

Torrent Pharma Research see more...

Overview Inc. Year: 1972Industry: Pharmaceuticals & Drugs

Torrent Pharmaceuticals Ltd is an India-based pharmaceutical business enterprise. The Company is engaged in studies, improvement, manufacturing and advertising of generic pharmaceutical formulations. It operates in the gastrointestinal (GI), central nervous system (CNS),therapeutic segments of cardiovascular (CV), and vitamins minerals nutritionals (VMN). It additionally has presence in therapeutic areas, consisting of anti-epileptic, anti-diabetic, anti-most cancers, anti-zits, corticosteroids and cosmeceuticals. It has developed complex formulations for global markets based totally on oral solids, injections, inhalation technologies, long-appearing depot injections ophthalmic, nasal, semisolids for outside packages and multi-particulate extended-launch oral structures. The Company is growing numerous in-house new chemical entities (NCE) inside the regions of metabolic, cardiovascular, gastrointestinal, dermatological and breathing problems. It has a presence across more than forty countries.

Read More..

Torrent Pharma Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Torrent Pharma Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Torrent Pharma Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 3365 3476 5420 4551 4244 5762 6168 6451 6742 7695 8533
Other Income 66 314 293 300 332 382 237 118 204 82 91
Total Income 3431 3789 5713 4851 4577 6144 6405 6569 6947 7777 8624
Total Expenditure 2335 2640 2779 3424 3337 4149 4251 4259 4642 5230 5644
Operating Profit 1096 1149 2934 1427 1240 1995 2154 2310 2305 2547 2981
Interest 58 173 180 202 294 481 430 334 236 298 303
Depreciation 79 180 213 269 384 579 607 610 602 672 761
Exceptional Income / Expenses 0 0 -193 0 0 0 0 0 0 0 0
Profit Before Tax 958 796 2348 955 562 935 1117 1366 1466 1577 1917
Provision for Tax 196 173 605 101 80 190 178 228 475 526 559
Profit After Tax 762 623 1743 854 482 745 939 1138 991 1051 1357
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 762 623 1743 854 482 745 939 1138 991 1051 1357
Adjusted Earnings Per Share 22.5 18.4 51.5 25.2 14.2 22 27.7 33.6 29.3 31.1 40.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 11% 10% 8% 10%
Operating Profit CAGR 17% 9% 8% 11%
PAT CAGR 29% 6% 13% 6%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 49% 29% 30% 20%
ROE Average 20% 18% 18% 23%
ROCE Average 21% 19% 17% 21%

Torrent Pharma Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 2290 2706 3707 4454 4556 5015 5121 6030 6345 6456 6829
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 744 2185 1784 2209 4111 3740 3140 2941 1972 2332 1604
Other Non-Current Liabilities 131 293 295 234 164 184 168 176 412 675 955
Total Current Liabilities 1167 1313 1502 1155 2988 3088 3387 2586 2423 3409 2989
Total Liabilities 4333 6497 7289 8051 11819 12027 11817 11733 11153 12872 12377
Fixed Assets 836 2764 2681 3523 7429 7425 7198 6741 6251 7972 7986
Other Non-Current Assets 824 1014 1469 982 752 853 800 850 841 973 650
Total Current Assets 2672 2719 3137 3545 3639 3749 3819 4142 3933 3927 3741
Total Assets 4333 6497 7289 8051 11819 12027 11817 11733 11153 12872 12377

Torrent Pharma Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 321 391 354 847 862 513 93 386 62 65 85
Cash Flow from Operating Activities 310 1065 2403 679 929 1232 1580 1573 2140 2265 2893
Cash Flow from Investing Activities -326 -2099 -586 -533 -4207 -373 269 -316 -160 -2384 -296
Cash Flow from Financing Activities 87 996 -1326 -131 2929 -928 -1555 -1581 -1977 81 -2578
Net Cash Inflow / Outflow 70 -38 491 16 -349 -69 294 -325 3 -38 19
Closing Cash & Cash Equivalent 391 353 847 862 513 444 386 62 65 85 105

Torrent Pharma Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 22.52 18.41 51.49 25.24 14.24 22.02 27.73 33.62 29.29 31.06 40.1
CEPS(Rs) 24.87 23.74 57.8 33.19 25.58 39.13 45.65 51.63 47.09 50.93 62.58
DPS(Rs) 10 11.25 35 14 7 8.5 32 35 48 22 28
Book NAV/Share(Rs) 67.65 79.93 109.53 131.58 134.62 148.17 151.29 178.15 187.47 190.75 201.76
Core EBITDA Margin(%) 30.55 23.98 48.55 24.54 21.08 27.69 30.64 33.45 30.6 31.42 33.18
EBIT Margin(%) 30.15 27.81 46.48 25.2 19.88 24.31 24.73 25.95 24.8 23.9 25.49
Pre Tax Margin(%) 28.42 22.85 43.17 20.79 13.06 16.05 17.85 20.85 21.36 20.1 22.01
PAT Margin (%) 22.61 17.89 32.04 18.6 11.2 12.8 15 17.37 14.44 13.4 15.58
Cash Profit Margin (%) 24.96 23.06 35.97 24.46 20.12 22.73 24.7 26.68 23.22 21.97 24.32
ROA(%) 19.83 11.51 25.29 11.14 4.85 6.25 7.87 9.66 8.66 8.75 10.75
ROE(%) 38.69 24.95 54.36 20.93 10.7 15.58 18.52 20.41 16.02 16.43 20.43
ROCE(%) 35.27 22.4 45.21 18.01 9.89 13.46 14.68 16.3 16.94 18.1 20.96
Receivable days 116.28 130.91 70.22 76.69 90.16 77.19 83.57 85.05 82.04 76.09 69.19
Inventory Days 75.31 77.31 58.76 79.57 98.86 83.26 83.6 95.25 98.61 79.08 66.39
Payable days 195.34 213.33 227.84 180.81 247.16 181.4 158.89 163.65 136.79 117.53 131.32
PER(x) 11.63 31.53 13.01 30.69 43.81 44.32 35.55 37.8 47.73 49.49 64.87
Price/Book(x) 3.87 7.26 6.12 5.89 4.64 6.59 6.52 7.13 7.46 8.06 12.89
Dividend Yield(%) 1.91 0.97 2.61 0.9 1.12 0.87 1.62 1.38 1.72 1.43 1.08
EV/Net Sales(x) 2.91 6.36 4.58 6.28 6.34 6.67 6.21 7.34 7.5 7.34 10.7
EV/Core EBITDA(x) 8.92 19.23 8.47 20.04 21.7 19.26 17.78 20.49 21.95 22.16 30.62
Net Sales Growth(%) 21.64 3.29 55.93 -16.02 -6.75 35.77 7.04 4.57 4.52 14.13 10.89
EBIT Growth(%) 44.87 -4.72 160.96 -54.22 -26.06 65.47 9.26 9.89 0.13 10.11 18.4
PAT Growth(%) 39.52 -18.25 179.69 -50.99 -43.57 54.64 25.9 21.24 -12.87 6.05 29.07
EPS Growth(%) 39.51 -18.25 179.69 -50.99 -43.57 54.64 25.9 21.24 -12.87 6.05 29.07
Debt/Equity(x) 0.49 0.93 0.61 0.55 1.28 1.12 1.04 0.73 0.53 0.71 0.49
Current Ratio(x) 2.29 2.07 2.09 3.07 1.22 1.21 1.13 1.6 1.62 1.15 1.25
Quick Ratio(x) 1.7 1.49 1.46 2.21 0.79 0.78 0.69 0.88 0.9 0.69 0.73
Interest Cover(x) 17.4 5.61 14.06 5.72 2.91 2.94 3.59 5.09 7.21 6.3 7.32
Total Debt/Mcap(x) 0.13 0.13 0.1 0.09 0.28 0.17 0.16 0.1 0.07 0.09 0.04

Torrent Pharma Shareholding Pattern

# Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
FII 10.8 11.37 12.09 12.04 12.84 13.15 14.09 14.14 14.22 14.46
DII 10.01 9.51 8.87 9 8.31 8 7.21 7.26 7.27 7.08
Public 7.95 7.88 7.8 7.71 7.6 7.6 7.45 7.36 7.26 7.21
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has reduced debt.

Cons

  • Debtor days have increased from 117.53 to 131.32days.
  • Stock is trading at 15.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Torrent Pharma News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!